
Episode #6: The Skinny on GLP-1s
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
このコンテンツについて
GLP-1 drugs like Ozempic and Mounjaro are being hyped as miracle weight loss solutions—but what happens when med spas start playing doctor with zero oversight? In this episode, we expose the dark underbelly of GLP-1 therapy in the aesthetics world: shady compounding pharmacies, dangerously unqualified staff, and patients ending up in the ER from improper dosing.
We break down how these amazing and life-changing drugs are being cheaply marketed as “skinny shots” with no real screening, no medical supervision, and no education on diet, exercise, or long-term safety. From body-shaming sales tactics to the 30% potency variance in off-label compounds, this episode is a must-listen for consumers, providers, and anyone curious about the latest med spa cash grab.
What we cover:
• The truth about compounded GLP-1s—and why they could be putting you at risk
• A real story of a patient hospitalized after a botched dose by an aesthetician
• Why med spas are skipping labs, coaching, and proper follow-up
• What ethical GLP-1 protocols should look like
Red flags, receipts, and the real science behind the skinny shot trend—this is the episode they don’t want you to hear.